Pharming (PHAR) Inventory (2018 - 2026)
Pharming's (PHAR) quarterly Inventory came in at $65.4 million in Q2 2026, up 2.69% YoY from $63.7 million in Q2 2025, and up 1.32% on a QoQ basis from $64.6 million in Q1 2026.
Pharming (PHAR) Inventory (2018 - 2026) Analysis & Trends
Pharming (PHAR) has 9 years of Inventory data on file, last reported at $65.4 million in Q2 2026.
- Quarterly Inventory rose 2.69% year-over-year to $65.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $65.4 million (up 2.69% YoY) and the FY2025 annual result came in at $64.9 million, up 16.47% from the prior year.
- Inventory improved to $65.4 million in Q2 2026, from $64.6 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $67.1 million in Q3 2025 to a low of -$4.3 million in Q4 2023.
- A 5-year average of $46.1 million and a median of $55.8 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory sank 7250.34% — and 2023, when it jumped 159390.84%.
- Tracing PHAR's Inventory over 5 years: stood at -$2.0 million in 2022, then tumbled by 116.95% to -$4.3 million in 2023, then soared by 1403.18% to $55.7 million in 2024, then increased by 16.47% to $64.9 million in 2025, then grew by 0.81% to $65.4 million in 2026.
- The last three Inventory figures came in at $65.4 million (Q2 2026), $64.6 million (Q1 2026), and $64.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | 65.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.43 Mn |
| Mar 31, 2026 | 64.58 Mn |
| Dec 31, 2025 | 64.90 Mn |
| Sep 30, 2025 | 67.14 Mn |
| Jun 30, 2025 | 63.72 Mn |
| Mar 31, 2025 | 59.35 Mn |
| Dec 31, 2024 | 55.72 Mn |
| Sep 30, 2024 | 62.23 Mn |
| Jun 30, 2024 | 59.19 Mn |
| Mar 31, 2024 | 55.88 Mn |
| Dec 31, 2023 | -4.28 Mn |
| Sep 30, 2023 | 53.44 Mn |
| Jun 30, 2023 | 53.04 Mn |
| Mar 31, 2023 | 48.13 Mn |
| Dec 31, 2022 | -1.97 Mn |
| Sep 30, 2022 | 33,506.00 |
| Jun 30, 2022 | 33.93 Mn |
| Mar 31, 2022 | 29.61 Mn |
| Dec 31, 2021 | 27,565.12 |
| Sep 30, 2021 | 25.10 Mn |